Patient Treatment Completed in Pivotal Trial Evaluating Allon's Davunetide

Patient treatment completed in pivotal trial evaluating Allon's davunetide

Filed under: drug treatment news stories

Allon is conducting the study under a Special Protocol Assessment with the U.S. Food and Drug Administration meaning the data from this study can be used as part of a marketing approval for davunetide. Allon estimates the market potential for the first …
Read more on Sacramento Bee